199 related articles for article (PubMed ID: 19933851)
1. Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production.
Boyd CR; Orr SJ; Spence S; Burrows JF; Elliott J; Carroll HP; Brennan K; Ní Gabhann J; Coulter WA; Jones C; Crocker PR; Johnston JA; Jefferies CA
J Immunol; 2009 Dec; 183(12):7703-9. PubMed ID: 19933851
[TBL] [Abstract][Full Text] [Related]
2. Interplay Between Sialic Acids, Siglec-E, and Neu1 Regulates MyD88- and TRIF-Dependent Pathways for TLR4-Activation During
Karmakar J; Mandal C
Front Immunol; 2021; 12():626110. PubMed ID: 33763070
[TBL] [Abstract][Full Text] [Related]
3. Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways.
Pang Z; Junkins RD; Raudonis R; MacNeil AJ; McCormick C; Cheng Z; Lin TJ
PLoS One; 2018; 13(5):e0197491. PubMed ID: 29799862
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of TLR-dependent MyD88 and TRIF signaling pathways by free zinc ions.
Brieger A; Rink L; Haase H
J Immunol; 2013 Aug; 191(4):1808-17. PubMed ID: 23863901
[TBL] [Abstract][Full Text] [Related]
6. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
7. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
8. AKT1 distinctively suppresses MyD88-depenedent and TRIF-dependent Toll-like receptor signaling in a kinase activity-independent manner.
Zenke K; Muroi M; Tanamoto KI
Cell Signal; 2018 Mar; 43():32-39. PubMed ID: 29242168
[TBL] [Abstract][Full Text] [Related]
9. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatase with proline-glutamine-serine-threonine-rich motifs negatively regulates TLR-triggered innate responses by selectively inhibiting IκB kinase β/NF-κB activation.
Zhang P; Liu X; Li Y; Zhu X; Zhan Z; Meng J; Li N; Cao X
J Immunol; 2013 Feb; 190(4):1685-94. PubMed ID: 23296707
[TBL] [Abstract][Full Text] [Related]
12. Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-β and RANTES production.
Siednienko J; Gajanayake T; Fitzgerald KA; Moynagh P; Miggin SM
J Immunol; 2011 Feb; 186(4):2514-22. PubMed ID: 21248248
[TBL] [Abstract][Full Text] [Related]
13. Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1.
Joung SM; Park ZY; Rani S; Takeuchi O; Akira S; Lee JY
J Immunol; 2011 Jan; 186(1):499-507. PubMed ID: 21106850
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive Siglec-E ligands on mouse aorta are up-regulated by LPS via NF-κB pathway.
Liu H; Zheng Y; Zhang Y; Li J; Fernandes SM; Zeng D; Li X; Schnaar RL; Jia Y
Biomed Pharmacother; 2020 Feb; 122():109760. PubMed ID: 31918287
[TBL] [Abstract][Full Text] [Related]
15. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
[TBL] [Abstract][Full Text] [Related]
16. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses.
Chi H; Barry SP; Roth RJ; Wu JJ; Jones EA; Bennett AM; Flavell RA
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2274-9. PubMed ID: 16461893
[TBL] [Abstract][Full Text] [Related]
17. Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1.
Chen GY; Brown NK; Wu W; Khedri Z; Yu H; Chen X; van de Vlekkert D; D'Azzo A; Zheng P; Liu Y
Elife; 2014 Sep; 3():e04066. PubMed ID: 25187624
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of CpG DNA on IFN-beta induction and STAT1 activation in murine macrophages versus dendritic cells: alternatively activated STAT1 negatively regulates TLR signaling in macrophages.
Schroder K; Spille M; Pilz A; Lattin J; Bode KA; Irvine KM; Burrows AD; Ravasi T; Weighardt H; Stacey KJ; Decker T; Hume DA; Dalpke AH; Sweet MJ
J Immunol; 2007 Sep; 179(6):3495-503. PubMed ID: 17785783
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression.
Medvedev AE; Kopydlowski KM; Vogel SN
J Immunol; 2000 Jun; 164(11):5564-74. PubMed ID: 10820230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
